BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carbajo-Lozoya J, Müller MA, Kallies S, Thiel V, Drosten C, von Brunn A. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res 2012;165:112-7. [PMID: 22349148 DOI: 10.1016/j.virusres.2012.02.002] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Desmazes-Dufeu N, Coltey B, Amari L, Gouitaa M, Touzery C, Reynaud-Gaubert M, Chanez P, Cassir N. Discordant courses of COVID-19 in a cohabiting couple of lung transplant recipients. Transpl Infect Dis 2021;23:e13410. [PMID: 32654244 DOI: 10.1111/tid.13410] [Reference Citation Analysis]
2 AbdulRahim N, McAdams M, Xu P, Wojciechowski D, La Hoz RM, Lu C, Vazquez MA, Hedayati SS. Association of Inflammatory Biomarkers with Immunosuppression Management and Outcomes in Kidney Transplant Recipients with COVID-19. Transplant Proc 2021;53:2451-67. [PMID: 34465422 DOI: 10.1016/j.transproceed.2021.08.002] [Reference Citation Analysis]
3 Vistoli F, Furian L, Maggiore U, Caldara R, Cantaluppi V, Ferraresso M, Zaza G, Cardillo M, Biancofiore G, Menichetti F, Russo A, Turillazzi E, Di Paolo M, Grandaliano G, Boggi U; Italian National Kidney Transplantation Network., the Joint Committee of the Italian Society of Organ Transplantation and the Italian Society of Nephrology. COVID-19 and kidney transplantation: an Italian Survey and Consensus. J Nephrol 2020;33:667-80. [PMID: 32495231 DOI: 10.1007/s40620-020-00755-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
4 Fishman JA, Grossi PA. Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve. Am J Transplant. 2020;20:1765-1767. [PMID: 32233057 DOI: 10.1111/ajt.15890] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 33.0] [Reference Citation Analysis]
5 NasrAllah MM, Osman NA, Elalfy M, Malvezzi P, Rostaing L. Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? Rev Med Virol 2021;31:1-9. [PMID: 32954602 DOI: 10.1002/rmv.2149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Morlacchi LC, Rossetti V, Gigli L, Amati F, Rosso L, Aliberti S, Nosotti M, Blasi F. COVID‐19 in lung transplant recipients: A case series from Milan, Italy. Transpl Infect Dis 2020;22. [DOI: 10.1111/tid.13356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Milewska A, Ciejka J, Kaminski K, Karewicz A, Bielska D, Zeglen S, Karolak W, Nowakowska M, Potempa J, Bosch BJ, Pyrc K, Szczubialka K. Novel polymeric inhibitors of HCoV-NL63. Antiviral Res 2013;97:112-21. [PMID: 23201315 DOI: 10.1016/j.antiviral.2012.11.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
8 Sun J, Fahmi NA, Nassereddeen H, Cheng S, Martinez I, Fan D, Yong J, Zhang W. Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells. Int J Mol Sci 2021;22:9684. [PMID: 34575842 DOI: 10.3390/ijms22189684] [Reference Citation Analysis]
9 Russell MR, Halnon NJ, Alejos JC, Salem MM, Reardon LC. COVID-19 in a pediatric heart transplant recipient: Emergence of donor-specific antibodies. J Heart Lung Transplant. 2020;39:732-733. [PMID: 32430156 DOI: 10.1016/j.healun.2020.04.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
10 Lai Q, Spoletini G, Bianco G, Graceffa D, Agnes S, Rossi M, Lerut J. SARS-CoV2 and immunosuppression: A double-edged sword. Transpl Infect Dis 2020;22:e13404. [PMID: 32639598 DOI: 10.1111/tid.13404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
11 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
12 Hage R, Steinack C, Benden C, Schuurmans M. COVID-19 in Patients with Solid Organ Transplantation: A Systematic Review. Transplantology 2020;1:1-15. [DOI: 10.3390/transplantology1010001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
13 Ma-Lauer Y, Lei J, Hilgenfeld R, von Brunn A. Virus-host interactomes--antiviral drug discovery. Curr Opin Virol 2012;2:614-21. [PMID: 23057872 DOI: 10.1016/j.coviro.2012.09.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
14 Myint PK, Carter B, Barlow-Pay F, Short R, Einarsson AG, Bruce E, McCarthy K, Verduri A, Collins J, Hesford J, Rickard F, Mitchell E, Holloway M, McGovern A, Vilches-Moraga A, Braude P, Pearce L, Stechman M, Price A, Quinn TJ, Clini E, Moug S, Hewitt J. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19. Ther Adv Drug Saf 2021;12:2042098620985690. [PMID: 33680426 DOI: 10.1177/2042098620985690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dirim AB, Demir E, Ucar AR, Garayeva N, Safak S, Oto OA, Yazici H, Alibeyoglu AM, Orhun G, Cagatay AA, Turkmen A. Fatal SARS-CoV-2 infection in a renal transplant recipient. CEN Case Rep 2020;9:409-12. [PMID: 32564306 DOI: 10.1007/s13730-020-00496-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
16 Jamieson AM. Host resilience to emerging coronaviruses. Future Virol 2016;11:529-34. [PMID: 32201496 DOI: 10.2217/fvl-2016-0060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
17 Machado DJB, Ianhez LE. COVID-19 pneumonia in kidney transplant recipients-Where we are? Transpl Infect Dis 2020;22:e13306. [PMID: 32364677 DOI: 10.1111/tid.13306] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
18 Parente A, Manzia TM, Angelico R, Tirotta F, Muiesan P, Tisone G, Framarino Dei Malatesta M. COVID-19, liver transplant, and immunosuppression: Allies or foes? Transpl Infect Dis 2021;23:e13417. [PMID: 32666588 DOI: 10.1111/tid.13417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Latif F, Farr MA, Clerkin KJ, Habal MV, Takeda K, Naka Y, Restaino S, Sayer G, Uriel N. Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. JAMA Cardiol 2020;5:1165-9. [PMID: 32402056 DOI: 10.1001/jamacardio.2020.2159] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 68.0] [Reference Citation Analysis]
20 Galimberti F, McBride J, Cronin M, Li Y, Fox J, Abrouk M, Herbst A, Kirsner RS. Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19. Clin Dermatol 2020;38:775-80. [PMID: 32419721 DOI: 10.1016/j.clindermatol.2020.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Wang AX, Quintero Cardona O, Ho DY, Busque S, Lenihan CR. Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients. Transpl Infect Dis 2021;23:e13423. [PMID: 32701196 DOI: 10.1111/tid.13423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 Bossini N, Alberici F, Delbarba E, Valerio F, Manenti C, Possenti S, Econimo L, Maffei C, Pola A, Terlizzi V, Salviani C, Moscato M, Pasquali S, Zambetti N, Tonoli M, Affatato S, Pecchini P, Viola FB, Malberti F, Depetri G, Gaggiotti M, Scolari F; Brescia Renal COVID task force. Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience. Am J Transplant 2020;20:3019-29. [PMID: 32627319 DOI: 10.1111/ajt.16176] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
23 Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG. Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19. Life Sci 2020;255:117842. [PMID: 32454157 DOI: 10.1016/j.lfs.2020.117842] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
24 Daoud A, Alqassieh A, Alkhader D, Posadas Salas MA, Rao V, Fülöp T, Soliman KM. Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? Ren Fail 2021;43:273-80. [PMID: 33491531 DOI: 10.1080/0886022X.2021.1876730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Rammohan A. Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing. World J Transplant 2020; 10(9): 267-276 [PMID: 32995321 DOI: 10.5500/wjt.v10.i9.267] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Bourgonje AR, van Linschoten RCA, West RL, van Dijk MA, van Leer-Buter CC, Kats-Ugurlu G, Pierik MJ, Festen EAM, Weersma RK, Dijkstra G. Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options. Therap Adv Gastroenterol 2021;14:17562848211012595. [PMID: 33995584 DOI: 10.1177/17562848211012595] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 von Brunn A, Ciesek S, von Brunn B, Carbajo-Lozoya J. Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication. Curr Opin Virol 2015;14:56-61. [PMID: 26318518 DOI: 10.1016/j.coviro.2015.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
28 de Wilde AH, Pham U, Posthuma CC, Snijder EJ. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology 2018;522:46-55. [PMID: 30014857 DOI: 10.1016/j.virol.2018.06.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
29 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
30 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
31 Onorati F, Myers P, Bajona P, Perrotti A, Mestres CA, Quintana E. Effects of COVID-19 pandemic on cardiac surgery practice in 61 Hospitals worldwide: results of a survey. J Cardiovasc Surg (Torino) 2020;61:763-8. [PMID: 32964896 DOI: 10.23736/S0021-9509.20.11556-8] [Reference Citation Analysis]
32 Hayashi K, Ito Y, Yamane R, Yoshizaki M, Matsushita K, Kajikawa G, Kozawa T, Mizutani T, Shimizu Y, Nagano K, Tachi K, Yoshioka K, Goto H. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome. Clin J Gastroenterol 2021;14:842-5. [PMID: 33675512 DOI: 10.1007/s12328-021-01374-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Steinack C, Hage R, Benden C, Schuurmans M. SARS-CoV-2 and Norovirus Co-Infection after Lung Transplantation. Transplantology 2020;1:16-23. [DOI: 10.3390/transplantology1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
34 Singhvi A, Barghash M, Lala A, Mitter SS, Parikh A, Oliveros E, Rollins BM, Brunjes DL, Alvarez-Garcia J, Johnston E, Ryan K, Itagaki S, Moss N, Pinney SP, Anyanwu A, Mancini D. Challenges in heart transplantation during COVID-19: A single-center experience. J Heart Lung Transplant 2020;39:894-903. [PMID: 32891266 DOI: 10.1016/j.healun.2020.06.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
35 Craig-Schapiro R, Salinas T, Lubetzky M, Abel BT, Sultan S, Lee JR, Kapur S, Aull MJ, Dadhania DM. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. Am J Transplant 2021;21:1576-85. [PMID: 33043597 DOI: 10.1111/ajt.16351] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
36 Perlin DV, Dymkov IN, Terentiev AV, Perlina AV. Is Kidney Transplantation From a COVID-19-Positive Deceased Donor Safe for the Recipient? Transplant Proc 2021;53:1138-42. [PMID: 33589232 DOI: 10.1016/j.transproceed.2021.01.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Jarrin Tejada CD, Zachariah M, Cruz ABV, Hussein S, Wipula E, Meeks N, Wolff J, Chandrasekar PH. Favorable outcome of COVID-19 among African American (AA) renal transplant recipients in Detroit. Clin Transplant 2021;35:e14169. [PMID: 33247978 DOI: 10.1111/ctr.14169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Adapa S, Konala VM, Naramala S, Daggubati SR, Koduri NM, Gayam V, Chenna A. COVID-19 in Renal Transplant Patient Presenting With Active Typical Symptoms and Resolved Atypical Symptoms. J Investig Med High Impact Case Rep 2020;8:2324709620949307. [PMID: 32779481 DOI: 10.1177/2324709620949307] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Rubin DT, Feuerstein JD, Wang AY, Cohen RD. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Gastroenterology. 2020;159:350-357. [PMID: 32283100 DOI: 10.1053/j.gastro.2020.04.012] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 53.0] [Reference Citation Analysis]
40 Michel S, Witt C, Gottlieb J, Aigner C. Impact of COVID-19 on Lung Transplant Activity in Germany-A Cross-Sectional Survey. Thorac Cardiovasc Surg 2021;69:92-4. [PMID: 32898894 DOI: 10.1055/s-0040-1715436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Alkadi MM, Al-Malki HA, Asim M, Fituri OM, Hamdi AF, Elidrisi RI, Abdul Rahiman R, Elshirbeny MF, Othman MA, Nauman A, Ashour A, Ghonimi TA, Tohid H, Jarman ME, Hamad A, Elshazly MB, Abuhelaiqa E. Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience. Transplant Proc 2021:S0041-1345(21)00405-X. [PMID: 34275597 DOI: 10.1016/j.transproceed.2021.06.001] [Reference Citation Analysis]
42 Gaston DC, Malinis M, Osborn R, Peaper DR, Landry M, Juthani-Mehta M, Azar MM. Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients. Am J Transplant 2021;21:1304-11. [PMID: 33043603 DOI: 10.1111/ajt.16357] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
43 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kawazoe M, Kihara M, Nanki T. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists. Pharmaceuticals (Basel) 2021;14:1256. [PMID: 34959657 DOI: 10.3390/ph14121256] [Reference Citation Analysis]
45 Vougogiannopoulou K, Corona A, Tramontano E, Alexis MN, Skaltsounis AL. Natural and Nature-Derived Products Targeting Human Coronaviruses. Molecules 2021;26:448. [PMID: 33467029 DOI: 10.3390/molecules26020448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
46 Hage R, Steinack C, Schuurmans MM. Calcineurin inhibitors revisited: A new paradigm for COVID-19? Braz J Infect Dis. 2020;24:365-367. [PMID: 32603679 DOI: 10.1016/j.bjid.2020.06.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
47 Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B. How should I manage immunosuppression in a kidney transplant patient with COVID-19? Nephrol Dial Transplant. 2020;35:899-904. [PMID: 32441741 DOI: 10.1093/ndt/gfaa130] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 22.5] [Reference Citation Analysis]
48 Esser-Nobis K, Harak C, Schult P, Kusov Y, Lohmann V. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication. Hepatology 2015;62:397-408. [PMID: 25866017 DOI: 10.1002/hep.27847] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
49 Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, Thaunat O, Legris T, Moal V, Westeel PF, Kamar N, Gatault P, Snanoudj R, Sicard A, Bertrand D, Colosio C, Couzi L, Chemouny JM, Masset C, Blancho G, Bamoulid J, Duveau A, Bouvier N, Chavarot N, Grimbert P, Moulin B, Le Meur Y, Hazzan M; French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98:1549-58. [PMID: 32853631 DOI: 10.1016/j.kint.2020.08.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 34.0] [Reference Citation Analysis]
50 Liao Y, Luo D, Peng K, Zeng Y. Cyclophilin A: a key player for etiological agent infection. Appl Microbiol Biotechnol 2021;105:1365-77. [PMID: 33492451 DOI: 10.1007/s00253-021-11115-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Toapanta N, Torres IB, Sellarés J, Chamoun B, Serón D, Moreso F. Kidney transplantation and COVID-19 renal and patient prognosis. Clin Kidney J 2021;14:i21-9. [PMID: 33815780 DOI: 10.1093/ckj/sfab030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
52 Tschopp J, L'Huillier AG, Mombelli M, Mueller NJ, Khanna N, Garzoni C, Meloni D, Papadimitriou-Olivgeris M, Neofytos D, Hirsch HH, Schuurmans MM, Müller T, Berney T, Steiger J, Pascual M, Manuel O, van Delden C; Swiss Transplant Cohort Study (STCS). First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study. Am J Transplant 2020;20:2876-82. [PMID: 32412159 DOI: 10.1111/ajt.16062] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
53 Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio. 2013;4:e00165-e00113. [PMID: 23631916 DOI: 10.1128/mbio.00165-13] [Cited by in Crossref: 182] [Cited by in F6Publishing: 144] [Article Influence: 20.2] [Reference Citation Analysis]
54 Saied EM, El-Maradny YA, Osman AA, Darwish AMG, Abo Nahas HH, Niedbała G, Piekutowska M, Abdel-Rahman MA, Balbool BA, Abdel-Azeem AM. A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19. Pharmaceutics 2021;13:1759. [PMID: 34834174 DOI: 10.3390/pharmaceutics13111759] [Reference Citation Analysis]
55 de Wilde AH, Zevenhoven-Dobbe JC, Beugeling C, Chatterji U, de Jong D, Gallay P, Szuhai K, Posthuma CC, Snijder EJ. Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture. Virology 2018;517:148-56. [PMID: 29249267 DOI: 10.1016/j.virol.2017.11.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
56 Raj K, Kaur K, Gupta GD, Singh S. Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1383-402. [PMID: 33961065 DOI: 10.1007/s00210-021-02091-5] [Reference Citation Analysis]
57 Rebendenne A, Roy P, Bonaventure B, Chaves Valadão AL, Desmarets L, Rouillé Y, Tauziet M, Arnaud-Arnould M, Giovannini D, Lee Y, DeWeirdt P, Hegde M, Garcia de Gracia F, McKellar J, Wencker M, Dubuisson J, Belouzard S, Moncorgé O, Doench JG, Goujon C. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses. bioRxiv 2021:2021. [PMID: 34031654 DOI: 10.1101/2021.05.19.444823] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Verleden GM, Godinas L, Lorent N, Van Bleyenbergh P, Dupont L, Delcroix M, Yserbyt J, Dooms C, Vos R. COVID-19 in lung transplant patients: A case series. Am J Transplant 2020;20:3234-8. [PMID: 32659857 DOI: 10.1111/ajt.16212] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
59 Ma-Lauer Y, Zheng Y, Malešević M, von Brunn B, Fischer G, von Brunn A. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication. Antiviral Res 2020;173:104620. [PMID: 31634494 DOI: 10.1016/j.antiviral.2019.104620] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
60 Teoh CW, Gaudreault-Tremblay MM, Blydt-Hansen TD, Goldberg A, Arora S, Feber J, Langlois V, Ruhl M, Phan V, Morgan C, Acott P, Hamiwka L. Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group. Can J Kidney Health Dis 2020;7:2054358120967845. [PMID: 33240516 DOI: 10.1177/2054358120967845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
61 Li Q, Cheng Q, Zhao Z, Dai N, Zeng L, Zhu L, Guo W, Li C, Wang J, Li S, Shen N, Ge Q. Novel coronavirus infection and acute kidney injury in two renal transplant recipients: a case report. J Int Med Res 2020;48:300060520964009. [PMID: 33100064 DOI: 10.1177/0300060520964009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
62 Fang FC, Benson CA, Del Rio C, Edwards KM, Fowler VG, Fredricks DN, Limaye AP, Murray BE, Naggie S, Pappas PG, Patel R, Paterson DL, Pegues DA, Petri WA, Schooley RT. COVID-19-Lessons Learned and Questions Remaining. Clin Infect Dis 2021;72:2225-40. [PMID: 33104186 DOI: 10.1093/cid/ciaa1654] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
63 Oguz EG, Atilgan KG, Cimen SG, Sahin H, Selen T, Ebinc FA, Cimen S, Ayli MD. COVID-19 infection in a kidney transplant recipient—special emphasis on pharmacokinetic interactions: A case report. World J Transplant 2020; 10(11): 365-371 [PMID: 33312897 DOI: 10.5500/wjt.v10.i11.365] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Paek JH, Kim Y, Park WY, Jin K, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Han S. Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality. PLoS One 2020;15:e0243528. [PMID: 33296419 DOI: 10.1371/journal.pone.0243528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Alberca RW, Benard G, Alberca GGF, Sato MN. SARS-CoV-2 infection in liver transplant recipients: A complex relationship. World J Gastroenterol 2021; 27(44): 7734-7738 [PMID: 34908810 DOI: 10.3748/wjg.v27.i44.7734] [Reference Citation Analysis]
66 García-Juárez I, Campos-Murguía A, Tovar-Méndez VH, Gabutti A, Ruiz I. Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus? Rev Gastroenterol Mex (Engl Ed) 2020;85:437-42. [PMID: 33032841 DOI: 10.1016/j.rgmx.2020.08.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Verma A, Khorsandi SE, Dolcet A, Prachalias A, Suddle A, Heaton N, Jassem W. Low prevalence and disease severity of COVID-19 in post-liver transplant recipients-A single centre experience. Liver Int 2020;40:1972-6. [PMID: 32471013 DOI: 10.1111/liv.14552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
68 Dix A, Czakai K, Leonhardt I, Schäferhoff K, Bonin M, Guthke R, Einsele H, Kurzai O, Löffler J, Linde J. Specific and Novel microRNAs Are Regulated as Response to Fungal Infection in Human Dendritic Cells. Front Microbiol 2017;8:270. [PMID: 28280489 DOI: 10.3389/fmicb.2017.00270] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
69 Latief M, Shafi O, Hassan Z, Farooq S, Abbas F. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in Kidney transplant patients: A case series and literature review. Med J Islam Repub Iran 2021;35:17. [PMID: 33996668 DOI: 10.47176/mjiri.35.17] [Reference Citation Analysis]
70 Guisado-Vasco P, Valderas-Ortega S, Carralón-González MM, Roda-Santacruz A, González-Cortijo L, Sotres-Fernández G, Martí-Ballesteros EM, Luque-Pinilla JM, Almagro-Casado E, La Coma-Lanuza FJ, Barrena-Puertas R, Malo-Benages EJ, Monforte-Gómez MJ, Diez-Munar R, Merino-Lanza E, Comeche-Casanova L, Remirez-de-Esparza-Otero M, Correyero-Plaza M, Recio-Rodríguez M, Rodríguez-López M, Sánchez-Manzano MD, Andreu-Vázquez C, Thuissard-Vasallo IJ, María-Tomé JME, Carnevali-Ruiz D. Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort). EClinicalMedicine 2020;28:100591. [PMID: 33078138 DOI: 10.1016/j.eclinm.2020.100591] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
71 Zhang H, Chen Y, Yuan Q, Xia QX, Zeng XP, Peng JT, Liu J, Xiao XY, Jiang GS, Xiao HY, Xie LB, Chen J, Liu JL, Xiao X, Su H, Zhang C, Zhang XP, Yang H, Li H, Wang ZD. Identification of Kidney Transplant Recipients with Coronavirus Disease 2019. Eur Urol. 2020;77:742-747. [PMID: 32249089 DOI: 10.1016/j.eururo.2020.03.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 37.0] [Reference Citation Analysis]
72 Devaux CA, Melenotte C, Piercecchi-Marti MD, Delteil C, Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front Med (Lausanne) 2021;8:663708. [PMID: 34552938 DOI: 10.3389/fmed.2021.663708] [Reference Citation Analysis]
73 Campbell CM, Guha A, Haque T, Neilan TG, Addison D. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review. J Clin Med 2020;9:E2935. [PMID: 32932930 DOI: 10.3390/jcm9092935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
74 Ma BM, Hung IFN, Chan GCW, Tam AR, Chan SSK, Wong BCK, Fukuda K, Ohno T, Yuen KY, Chan TM. Case of "relapsing" COVID-19 in a kidney transplant recipient. Nephrology (Carlton) 2020;25:933-6. [PMID: 32951300 DOI: 10.1111/nep.13786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
75 Shaikh N, Khatib MY, Alwraidat MA, Ananthegowda DC, Othman M, Aroos A, Jujjavarapu SB, Banerjee S, Nasir Z, Mohamed AS, Elshafei MS, Almaslamani MA, Nashwan AJ. Clinical outcomes of post-renal transplant patients with COVID-19 infection in the ICU: A single-center case series. Clin Case Rep 2021;9:e04513. [PMID: 34322259 DOI: 10.1002/ccr3.4513] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Carey SA, Afzal A, Jamil A, Williams S, Gottlieb RL. Outpatient COVID-19 surveillance testing in orthotopic heart transplant recipients. Clin Transplant 2020;34:e14105. [PMID: 32978777 DOI: 10.1111/ctr.14105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
77 Sanclemente-Alaman I, Moreno-Jiménez L, Benito-Martín MS, Canales-Aguirre A, Matías-Guiu JA, Matías-Guiu J, Gómez-Pinedo U. Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2. Front Immunol 2020;11:2163. [PMID: 32983181 DOI: 10.3389/fimmu.2020.02163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
78 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
79 Solanich X, Antolí A, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Molina M, Sabater J, Bas J, Mensa-Vilaró A, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Arregui L, Tebé C, Hereu P, Videla S, Corbella X. Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol. Contemp Clin Trials Commun 2021;21:100716. [PMID: 33495742 DOI: 10.1016/j.conctc.2021.100716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
80 Shafiekhani M, Kazemi K, Bahador A, Imanieh MH, Karimzadeh P. Pediatric liver and kidney transplantation in the era of COVID-19: a follow-up study from a tertiary referral center in Iran. BMC Surg. 2021;21:240. [PMID: 33975594 DOI: 10.1186/s12893-021-01226-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Adrogué AH, Mithani F, Ibrahim HN, Schwartz MR, Gaber L, Hebert SA, Adrogué HE. A Kidney Transplant Recipient With Coronavirus Disease 2019: Utility of a Prognostication Score. Transplant Proc 2020;52:2688-92. [PMID: 32980137 DOI: 10.1016/j.transproceed.2020.08.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
82 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
83 Quinteros JA, Markham PF, Lee SW, Hewson KA, Hartley CA, Legione AR, Coppo MJ, Vaz PK, Browning GF. Analysis of the complete genomic sequences of two virus subpopulations of the Australian infectious bronchitis virus vaccine VicS. Avian Pathol 2015;44:182-91. [PMID: 25721384 DOI: 10.1080/03079457.2015.1022857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
84 Solanich X, Antolí A, Rocamora-Blanch G, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Riera-Mestre A, Bas J, Vicens-Zygmunt V, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Mensa-Vilaró A, Arregui L, Tebe C, Videla S, Hereu P, Corbella X. Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. Front Med (Lausanne) 2021;8:691712. [PMID: 34195214 DOI: 10.3389/fmed.2021.691712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Willicombe M, Thomas D, McAdoo S. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J Am Soc Nephrol. 2020;31:1145-1146. [PMID: 32312797 DOI: 10.1681/asn.2020030348] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 23.5] [Reference Citation Analysis]
86 Goujon C, Rebendenne A, Roy P, Bonaventure B, Valadao AC, Desmarets L, Rouillé Y, Tauziet M, Arnaud-Arnould M, Giovannini D, Lee Y, DeWeirdt P, Hegde M, de Gracia FG, McKellar J, Wencker M, Dubuisson J, Belouzard S, Moncorgé O, Doench J. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. Res Sq 2021:rs. [PMID: 34075371 DOI: 10.21203/rs.3.rs-555275/v1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. [PMID: 32256705 DOI: 10.3332/ecancer.2020.1022] [Cited by in Crossref: 209] [Cited by in F6Publishing: 211] [Article Influence: 104.5] [Reference Citation Analysis]
88 Tepasse PR, Hafezi W, Lutz M, Kühn J, Wilms C, Wiewrodt R, Sackarnd J, Keller M, Schmidt HH, Vollenberg R. Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol 2020;190:185-8. [PMID: 32557623 DOI: 10.1111/bjh.16896] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 27.5] [Reference Citation Analysis]
89 Pearson MM, Limaye AP, Biggins SW. Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19. Gastroenterology. 2021;160:1012-1013. [PMID: 33387518 DOI: 10.1053/j.gastro.2020.12.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Tanaka Y, Sato Y, Sasaki T. Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B. J Gen Virol 2017;98:190-200. [PMID: 27902373 DOI: 10.1099/jgv.0.000663] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
91 Poulsen NN, von Brunn A, Hornum M, Blomberg Jensen M. Cyclosporine and COVID-19: Risk or favorable? Am J Transplant 2020;20:2975-82. [PMID: 32777170 DOI: 10.1111/ajt.16250] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
92 Kant S, Menez SP, Hanouneh M, Fine DM, Crews DC, Brennan DC, Sperati CJ, Jaar BG. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol 2020;21:449. [PMID: 33109103 DOI: 10.1186/s12882-020-02112-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
93 L'Huillier AG, Danziger-Isakov L, Chaudhuri A, Green M, Michaels MG, M Posfay-Barbe K, van der Linden D, Verma A, McCulloch M, Ardura MI. SARS-CoV-2 and pediatric solid organ transplantation: Current knowns and unknowns. Pediatr Transplant 2021;25:e13986. [PMID: 33689201 DOI: 10.1111/petr.13986] [Reference Citation Analysis]
94 Tanaka Y, Amano A, Morisaki M, Sato Y, Sasaki T. Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus. Antiviral Res 2016;126:1-7. [PMID: 26675666 DOI: 10.1016/j.antiviral.2015.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
95 Bayat M, Asemani Y, Mohammadi MR, Sanaei M, Namvarpour M, Eftekhari R. An overview of some potential immunotherapeutic options against COVID-19. Int Immunopharmacol 2021;95:107516. [PMID: 33765610 DOI: 10.1016/j.intimp.2021.107516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Giannini M, Ohana M, Nespola B, Zanframundo G, Geny B, Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J 2020;56:2001618. [PMID: 32631836 DOI: 10.1183/13993003.01618-2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
97 Robinson C, Ruhl M, Kirpalani A, Alabbas A, Noone D, Teoh CW, Langlois V, Phan V, Lemaire M, Chanchlani R. Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team. Can J Kidney Health Dis 2020;7:2054358120970713. [PMID: 33240518 DOI: 10.1177/2054358120970713] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Sanders DW, Jumper CC, Ackerman PJ, Bracha D, Donlic A, Kim H, Kenney D, Castello-Serrano I, Suzuki S, Tamura T, Tavares AH, Saeed M, Holehouse AS, Ploss A, Levental I, Douam F, Padera RF, Levy BD, Brangwynne CP. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation. Elife 2021;10:e65962. [PMID: 33890572 DOI: 10.7554/eLife.65962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
99 Hoek RAS, Manintveld OC, Betjes MGH, Hellemons ME, Seghers L, Van Kampen JAA, Caliskan K, van de Wetering J, van den Hoogen M, Metselaar HJ, Hesselink DA; Rotterdam Transplant Group. COVID-19 in solid organ transplant recipients: a single-center experience. Transpl Int 2020;33:1099-105. [PMID: 32460390 DOI: 10.1111/tri.13662] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 26.0] [Reference Citation Analysis]
100 van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, Kolundzic N, Abdulle AE, van der Voort PH, Olde Rikkert MG, van der Hoeven JG, den Dunnen WF, Hillebrands JL, van Goor H. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol 2021;254:307-31. [PMID: 33586189 DOI: 10.1002/path.5642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
101 Bösch F, Börner N, Kemmner S, Lampert C, Jacob S, Koliogiannis D, Stangl M, Michel S, Kneidinger N, Schneider C, Fischereder M, Irlbeck M, Denk G, Werner J, Angele MK, Guba MO. Attenuated early inflammatory response in solid organ recipients with COVID-19. Clin Transplant 2020;34:e14027. [PMID: 32589760 DOI: 10.1111/ctr.14027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
102 Imam A, Tzukert K, Merhav H, Imam R, Abu-Gazala S, Abel R, Elhalel MD, Khalaileh A. Practical recommendations for kidney transplantation in the COVID-19 pandemic. World J Transplant 2020; 10(9): 223-229 [PMID: 32995318 DOI: 10.5500/wjt.v10.i9.223] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
103 de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol. 2018;419:1-42. [PMID: 28643204 DOI: 10.1007/82_2017_25] [Cited by in Crossref: 106] [Cited by in F6Publishing: 144] [Article Influence: 35.3] [Reference Citation Analysis]
104 Carbajo-Lozoya J, Ma-Lauer Y, Malešević M, Theuerkorn M, Kahlert V, Prell E, von Brunn B, Muth D, Baumert TF, Drosten C, Fischer G, von Brunn A. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. Virus Res 2014;184:44-53. [PMID: 24566223 DOI: 10.1016/j.virusres.2014.02.010] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
105 Sebastian S, Gonzalez HA, Peyrin-Biroulet L. Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease. J Crohns Colitis. 2020;14:1632-1643. [PMID: 32520312 DOI: 10.1093/ecco-jcc/jjaa120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
106 Değirmenci MFK, Yalçındağ FN, Tugal-Tutkun İ. COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology. Turk J Ophthalmol 2021;51:231-42. [PMID: 34461710 DOI: 10.4274/tjo.galenos.2021.68252] [Reference Citation Analysis]
107 Koczulla RA, Sczepanski B, Koteczki A, Kuhnert S, Hecker M, Askevold I, Schneider C, Michel S, Kneidinger N. SARS-CoV-2 infection in two patients following recent lung transplantation. Am J Transplant. 2020;. [PMID: 32400084 DOI: 10.1111/ajt.15998] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
108 Rieker L, Hofer J, Petzold G, Ellenrieder V, Amanzada A. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report. BMC Gastroenterol 2022;22:22. [PMID: 35033015 DOI: 10.1186/s12876-022-02094-3] [Reference Citation Analysis]
109 Belli LS, Fondevila C, Cortesi PA, Conti S, Karam V, Adam R, Coilly A, Ericzon BG, Loinaz C, Cuervas-Mons V, Zambelli M, Llado L, Diaz-Fontenla F, Invernizzi F, Patrono D, Faitot F, Bhooori S, Pirenne J, Perricone G, Magini G, Castells L, Detry O, Cruchaga PM, Colmenero J, Berrevoet F, Rodriguez G, Ysebaert D, Radenne S, Metselaar H, Morelli C, De Carlis LG, Polak WG, Duvoux C; ELITA-ELTR COVID-19 Registry. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study. Gastroenterology 2021;160:1151-1163.e3. [PMID: 33307029 DOI: 10.1053/j.gastro.2020.11.045] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
110 Solanich X, Padullés N, Niubó J, Videla S, Antolí A, Rocamora-Blanch G, Corbella X. Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? J Intern Med 2021;289:926-7. [PMID: 33634528 DOI: 10.1111/joim.13264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 2021;:119201. [PMID: 33607159 DOI: 10.1016/j.lfs.2021.119201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
112 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
113 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Reference Citation Analysis]
114 Owji H, Negahdaripour M, Hajighahramani N. Immunotherapeutic approaches to curtail COVID-19. Int Immunopharmacol 2020;88:106924. [PMID: 32877828 DOI: 10.1016/j.intimp.2020.106924] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
115 Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, Kim AK, Avdic E, Petty B, Strout S, Fine DM, Niranjan-Azadi A, Garneau WM, Cameron AM, Monroy Trujillo JM, Gurakar A, Avery R. Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. Am J Transplant 2020;20:2254-9. [PMID: 32359210 DOI: 10.1111/ajt.15985] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
116 Abu Jawdeh BG. COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges. Adv Chronic Kidney Dis 2020;27:383-9. [PMID: 33308503 DOI: 10.1053/j.ackd.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
117 Aigner C, Dittmer U, Kamler M, Collaud S, Taube C. COVID-19 in a lung transplant recipient. J Heart Lung Transplant. 2020;39:610-611. [PMID: 32340870 DOI: 10.1016/j.healun.2020.04.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
118 Rossi G, Galosi L, Gavazza A, Cerquetella M, Mangiaterra S. Therapeutic approaches to coronavirus infection according to "One Health" concept. Res Vet Sci 2021;136:81-8. [PMID: 33588098 DOI: 10.1016/j.rvsc.2021.02.009] [Reference Citation Analysis]
119 Schoot TS, Kerckhoffs APM, Hilbrands LB, van Marum RJ. Immunosuppressive Drugs and COVID-19: A Review. Front Pharmacol 2020;11:1333. [PMID: 32982743 DOI: 10.3389/fphar.2020.01333] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
120 Esmaeilzadeh A, Jafari D, Tahmasebi S, Elahi R, Khosh E. Immune-Based Therapy for COVID-19. Adv Exp Med Biol 2021;1318:449-68. [PMID: 33973194 DOI: 10.1007/978-3-030-63761-3_26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Alberca RW, Alberca GGF, Netto LC, Orfali RL, Gozzi-silva SC, da Silva Duarte AJ, Aoki V, Sato MN, Benard G. COVID-19 Severity and Mortality in Solid Organ Transplantation: Differences between Liver, Heart, and Kidney Recipients. Transplantology 2021;2:296-303. [DOI: 10.3390/transplantology2030030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Silva F, Cipriano A, Cruz H, Tavares J, Fragoso J, Malheiro J, Almeida M, Martins S, Abreu M, Pedroso S, Dias L, Henriques AC. SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases. Transpl Infect Dis 2021;23:e13394. [PMID: 32597550 DOI: 10.1111/tid.13394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
123 Allegra A, Di Gioacchino M, Tonacci A, Musolino C, Gangemi S. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications. Int J Mol Sci 2020;21:E4782. [PMID: 32640747 DOI: 10.3390/ijms21134782] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
124 Ghaffari Rahbar M, Nafar M, Khoshdel A, Dalili N, Abrishami A, Firouzan A, Poorrezagholi F, Samadian F, Ziaie S, Fatemizadeh S, Samavat S. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22:e13406. [PMID: 32654357 DOI: 10.1111/tid.13406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
125 Cavagna L, Seminari E, Zanframundo G, Gregorini M, Di Matteo A, Rampino T, Montecucco C, Pelenghi S, Cattadori B, Pattonieri EF, Vitulo P, Bertani A, Sambataro G, Vancheri C, Biglia A, Bozzalla-Cassione E, Bonetto V, Monti MC, Ticozzelli E, Turco A, Oggionni T, Corsico A, Bertuccio F, Zuccaro V, Codullo V, Morosini M, Marena C, Gnecchi M, Pellegrini C, Meloni F. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy. Microorganisms 2020;8:E977. [PMID: 32629788 DOI: 10.3390/microorganisms8070977] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
126 Ozkok A, Alpay N, Alan S, Bakan ND, Soysal F, Yazici H, Ekşioğlu-Demiralp E, Yildiz A. Immunological parameters associated with the severity of COVID-19 pneumonia in kidney transplant recipients. Int Urol Nephrol 2021. [PMID: 34415473 DOI: 10.1007/s11255-021-02947-y] [Reference Citation Analysis]
127 Ahmadpoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection. Transpl Int. 2020;33:824-825. [PMID: 32236983 DOI: 10.1111/tri.13611] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 33.0] [Reference Citation Analysis]
128 Santos A, Sousa LL, Calça R, Lima A, Nascimento C, Jorge C, Adragão T, Bruges M, Peres S, Weigert A. SARS-CoV-2 infection in kidney transplant recipients: clinical impact and outcomes - a single center experience. J Bras Nefrol 2021:S0101-28002021005078301. [PMID: 34812470 DOI: 10.1590/2175-8239-JBN-2021-0164] [Reference Citation Analysis]
129 Sadia A, Basra MAR. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome. Drug Dev Res 2020. [PMID: 32662099 DOI: 10.1002/ddr.21710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]